Work

Vaccinating against GD3 ganglioside using BEC2 anti-idiotypic monoclonal antibody.

Year: 2003

Type: article

Source: PubMed

Author: Paul B Chapman

Institution: Memorial Sloan Kettering Cancer Center

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Cancer Institute

Award: IMMUNIZATION AGAINST TUMOR CELL ANTIGENS

OpenAlex ID: W65839805

FWCI: 1.661

Cites:

Cited by: 32

Related to: 10